AMGEN INC

AMGNNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$36.8B

▲ 10.0% YoY

Net Income

$7.7B

▲ 88.5% YoY

EPS

$14.23

▲ 88.2% YoY

Cash

$9.1B

▼ 23.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.